Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Armesto

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Actas Dermo-Sifiliograficas|April 17, 2025
Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical PracticeB Butrón-Bris, M Llamas-Velasco, S Armesto, et al.
Actas Dermo-Sifiliograficas|June 14, 2024
Measurement Assessment of Minimal Disease Activity In Psoriasis in Spain: A National Cross-Sectional StudyG Carretero Hernández, M Ara Martín, S Armesto Alonso, et al.
Actas Dermo-Sifiliograficas|October 10, 2024
[Translated article] Measurement Assessment of Minimal Disease Activity in Psoriasis in Spain: A National Cross-Sectional StudyG Carretero Hernández, M Ara Martín, S Armesto Alonso, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 10, 2020
Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis GroupE Del Alcázar, J A Suárez-Pérez, S Armesto, et al.
The Australasian Journal of Dermatology|July 12, 2023
Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish populationA Sahuquillo-Torralba, M Hospital-Gil, E Vilarrasa-Rull, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Actas Dermo-Sifiliograficas|April 17, 2025
Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical PracticeB Butrón-Bris, M Llamas-Velasco, S Armesto, et al.
Actas Dermo-Sifiliograficas|June 14, 2024
Measurement Assessment of Minimal Disease Activity In Psoriasis in Spain: A National Cross-Sectional StudyG Carretero Hernández, M Ara Martín, S Armesto Alonso, et al.
Actas Dermo-Sifiliograficas|October 10, 2024
[Translated article] Measurement Assessment of Minimal Disease Activity in Psoriasis in Spain: A National Cross-Sectional StudyG Carretero Hernández, M Ara Martín, S Armesto Alonso, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 10, 2020
Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis GroupE Del Alcázar, J A Suárez-Pérez, S Armesto, et al.
The Australasian Journal of Dermatology|July 12, 2023
Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish populationA Sahuquillo-Torralba, M Hospital-Gil, E Vilarrasa-Rull, et al.
Pageof 2